Several microRNAs are implicated in inflammation-associated carcinogenesis, and genetic ablation of NOS2 in a genetically engineered mouse model of KRAS-induced lung cancer reduced the expression of oncomir-21 [20, 21]. The gene discussed is KRAS; the disease is lung cancer.